In summary, we can be confident that POC Hb (HemoCue) performed well in a population with suspected severe anaemia and if implemented would result in savings across the health services if blood transfusion services required that a transfusion could only be ordered if supported by a Hb test. The gene discussed is GSTM1; the disease is anemia.